Detalles de la búsqueda
1.
Engineered bone marrow as a clinically relevant ex vivo model for primary bone cancer research and drug screening.
Proc Natl Acad Sci U S A
; 120(39): e2302101120, 2023 09 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37729195
2.
Emerging innovations and advancements in the treatment of extremity and truncal soft tissue sarcomas.
J Surg Oncol
; 129(1): 97-111, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38010997
3.
Clinical features and outcomes of young patients with low-grade non-rhabdomyosarcoma soft tissue sarcomas treated with a risk-based strategy: A report from Children's Oncology Group study ARST0332.
Pediatr Blood Cancer
; : e31062, 2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38757485
4.
The MOTION study: a randomized, phase III study of vimseltinib for the treatment of tenosynovial giant cell tumor.
Future Oncol
; 20(10): 593-601, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37593881
5.
Controversies in Oncologic Pediatric Limb Salvage.
Instr Course Lect
; 73: 387-398, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38090911
6.
Socioeconomic disparities in musculoskeletal oncology.
J Surg Oncol
; 128(3): 425-429, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37537984
7.
The dynamic microenvironment associated with metastatic bone disease: Current concepts.
J Surg Oncol
; 128(3): 468-477, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37226887
8.
Socioeconomic and insurance-related disparities in disease-specific survival among patients with metastatic bone disease.
J Surg Oncol
; 127(1): 159-173, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36121418
9.
Neoadjuvant pazopanib in nonrhabdomyosarcoma soft tissue sarcomas (ARST1321): A report of major wound complications from the Children's Oncology Group and NRG Oncology.
J Surg Oncol
; 127(5): 871-881, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36779385
10.
Non-Private Health Insurance Predicts Advanced Stage at Presentation and Amputation in Lower Extremity High Grade Bone Sarcoma: A National Cancer Database Study : Amputation Predicts Survival: An Effect Most Pronounced in Pediatric and AYA Age Group.
Ann Surg Oncol
; 2022 Mar 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35314919
11.
Impact of local treatment modality on overall- and disease-specific survival for nonmetastatic pelvic and sacral Ewing sarcoma.
J Surg Oncol
; 126(3): 577-587, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35585834
12.
Sex, racial/ethnic and socioeconomic disparities in patients with metastatic bone disease.
J Surg Oncol
; 125(4): 766-774, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34889456
13.
What Are the Long-term Surgical Outcomes of Compressive Endoprosthetic Osseointegration of the Femur with a Minimum 10-year Follow-up Period?
Clin Orthop Relat Res
; 480(3): 539-548, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34559734
14.
Tumors and Tumorlike Conditions of Which Every Orthopaedic Surgeon Should Be Aware.
Instr Course Lect
; 71: 231-248, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35254786
15.
Is osseous reattachment of the greater trochanter necessary compared to soft-tissue-only abductor repair in proximal femoral megaprosthesis reconstruction?
J Surg Oncol
; 124(1): 115-123, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33765357
16.
Primary mobile vertebral column sarcomas: Prognostic factors vary by histologic subtypes.
J Surg Oncol
; 124(4): 635-645, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34091907
17.
Malignant neoplasms originating from the bones of the foot: Predilection of hematological malignancies and sex-related and ethnic disparities in amputation.
J Surg Oncol
; 124(8): 1468-1476, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34351631
18.
Prognostic factors, disparity, and equity variables impacting prognosis in bone sarcomas of the hand: SEER database review.
J Surg Oncol
; 124(8): 1515-1522, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34432316
19.
A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective study.
Lancet Oncol
; 21(1): 145-161, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31786124
20.
Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trial.
Lancet Oncol
; 21(8): 1110-1122, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32702309